entertainment -WSS

entertainment

author：knowledge 2025-09-30 22:06:11 - browse：366

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Impact of Dobbs ruling felt at reproductive medicine meeting

entertainment

WSS

The battle over 'scope creep' and who gets to be called 'doctor'

What it's like to live with paralysis for one psychologist

Former reverend arrested for allegedly killing 8

Roche’s Alnylam deal shows drug firms interested in heart drugs

STAT Readout Newsletter: Today's biggest biotech updates

Medicare reduced heart disease by changing how it pays doctors

leisure time

entertainment

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Summit: How a Chicago ER doctor tackles gun violence

How to save PrEP access — and even expand it

Why health workers in Gaza are injured or die at high rates

Anesthesiologist group: stop taking Ozempic before surgery

STAT Summit: GSK CEO on pharma giant's new direction

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden warns of ‘dark winter’ during final presidental debate

Walensky prepares to leave CDC — and Congress — behind

HHS leader on health, climate change and biopharma emissions

knowledge

Why health workers in Gaza are injured or die at high rates

New Alzheimer's drugs heat up race for early detection blood tests

Device maker Teleflex to acquire urology company for $600M

'Investigate these claims': UFO transparency at center of House hearing

What it's like to live with paralysis for one psychologist

The explosion of genetic testing requires a new approach

focus

hotspot

entertainment

leisure time